Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-α, IL-1β and IL-1Ra

被引:36
作者
Sandler, C.
Lindstedt, K. A.
Joutsiniemi, S.
Lappalainen, J.
Juutilainen, T.
Kolah, J.
Kovanen, P. T.
Eklund, K. K.
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Div Rheumatol, Helsinki, Finland
[2] Wihuri Res Inst, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Orthoped Surg, Helsinki, Finland
关键词
rheumatoid arthritis; mast cell; cytokine;
D O I
10.1007/s00011-007-6135-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objectives and Design: To study the consequences of mast cell activation in human synovial tissue. Methods: Synovial tissue was obtained from 18 RA patients and mast cells was selectively activated in synovial tissue explant cultures. Expression of TNF-alpha, IL-1 beta and IL-1Ra were determined and tissue distribution of IL-1 beta was studied. Results: Compared to untreated synovia, selective activation of synovial mast cells increased significantly the production of TNF-alpha (0.49 +/- 0.88 vs. 4.56 +/- 3.18 pg/mg wet tissue, p < 0.001) and IL-1 beta (0.058 +/- 0.032 vs. 2.55 +/- 1.98 pg/mg wet tissue, p = 0.013). The expression of TNF-alpha and IL-1 beta mRNA increased significantly (19-fold (p = 0.009) and 13-fold (p = 0.031), respectively). Mast cell activation induced IL-1 beta expression in particular in nearby CD68 positive synovial macrophages. Secretion of IL-1Ra was also increased but to a lesser degree than that of IL-1 beta. Conclusions: Synovial mast cells produce proinflammmatory cytokines and may thus contribute to the inflammation in RA.
引用
收藏
页码:230 / 239
页数:10
相关论文
共 25 条
[1]   BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP ;
WELGUS, HG ;
THOMPSON, RC ;
EISENBERG, SP .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1694-1697
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   The role of the interleukin-1 receptor antagonist in blocking inflammation mediated by interleukin-1 [J].
Dinarello, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10) :732-734
[4]   Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases [J].
Eklund, KK ;
Joensuu, H .
ANNALS OF MEDICINE, 2003, 35 (05) :362-367
[5]   Anti-TNFα therapy of rheumatoid arthritis:: what have we learned? [J].
Feldmann, M ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :163-196
[6]   Evolving concepts of rheumatoid arthritis [J].
Firestein, GS .
NATURE, 2003, 423 (6937) :356-361
[7]   MAST-CELLS AS A SOURCE OF BOTH PREFORMED AND IMMUNOLOGICALLY INDUCIBLE TNF-ALPHA CACHECTIN [J].
GORDON, JR ;
GALLI, SJ .
NATURE, 1990, 346 (6281) :274-276
[8]   Mast cell responses in rheumatoid synovium - Association of the MC(TC) subset with matrix turnover and clinical progression [J].
GotisGraham, I ;
McNeil, HP .
ARTHRITIS AND RHEUMATISM, 1997, 40 (03) :479-489
[9]  
GRUBER B, 1988, CLIN EXP IMMUNOL, V71, P289
[10]   Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice [J].
Horai, R ;
Saijo, S ;
Tanioka, M ;
Nakae, S ;
Sudo, K ;
Okahara, A ;
Ikuse, T ;
Asano, M ;
Iwakura, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :313-320